VELCADE Side Effects

7023444-0 | Chest Pain, Fall, Hip Fracture
on Sep 22, 2010 Female patient from UNITED STATES , weighting 219.0 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), fall (What is fall?), hip fracture. Velcade dosage: Unk. Patient was hospitalized.

7023438-5 | Diarrhoea, Hypotension, International Normalised Ratio Increased, Tumour Lysis Syndrome
Patient was taking Velcade (View Usage). Patient had the following side effects: diarrhoea, hypotension, international normalised ratio increased, tumour lysis syndrome on Sep 21, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 170.4 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Velcade dosage: 1.3 Mg/m2, Cyclic. During the same period patient was treated with DEXAMETHASONE (20 Mg, Cyclic) (View Dexamethasone Review and Dexamethasone Label ), LENALIDOMIDE (25 Mg, Cyclic) (View Lenalidomide Review and Lenalidomide Label ), ASPIRIN (325 Mg, Qd) (View Aspirin Review and Aspirin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ), SOTALOL (View Sotalol Review and Sotalol Label ). Patient was hospitalized.

7018440-3 | Cardiomegaly, Cytomegalovirus Infection, Dilatation Atrial, Interstitial Lung Disease, Oedema Peripheral, Pneumocystis Jiroveci Pneumonia, Respiratory Failure
Adverse event was reported on Sep 13, 2010 by a Female patient taking Velcade (View Usage) (Dosage: 1.1 Mg/m2, Intravenous) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: JAPAN , 75 years of age, weighting 70.55 lb, After Velcade was administered, patient had the following side effects: cardiomegaly, cytomegalovirus infection (What is cytomegalovirus infection?), dilatation atrial, interstitial lung disease, oedema peripheral, pneumocystis jiroveci pneumonia, respiratory failure. During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), MAGLAX (MAGNESIUM OXIDE) (View Maglax (magnesium Oxide) Review and Maglax (magnesium Oxide) Label ), PANTOSIN (PANTETHINE) (View Pantosin (pantethine) Review and Pantosin (pantethine) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ALKERAN (View Alkeran Review and Alkeran Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

7013006-3 | Cardiac Failure, Hypotension, Ventricular Dysfunction
on Sep 10, 2010 Male patient from SWEDEN , 85 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, hypotension, ventricular dysfunction. Velcade dosage: 2.4 Mg, Intravenous. During the same period patient was treated with DOXAZOSIN MESYLATE (4 Mg, Oral) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), RAMIPRIL (1.25 Mg, Oral) (View Ramipril Review and Ramipril Label ), BISOPROLOL FUMARATE (1.25 Mg, Oral) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), PLAVIX (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ), AVODART /USA/ (DUTASTERIDE) (View Avodart /usa/ (dutasteride) Review and Avodart /usa/ (dutasteride) Label ). Patient was hospitalized.


7012947-0 | Dilatation Ventricular, Hypoxia, Pulmonary Hypertension, Pulmonary Oedema, Respiratory Distress, Tachycardia
on Sep 13, 2010 Male patient from POLAND , 64 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). Patient had the following side effects: dilatation ventricular, hypoxia, pulmonary hypertension (What is pulmonary hypertension?), pulmonary oedema, respiratory distress, tachycardia. Velcade dosage: 2.2 Mg, Intravenous. During the same period patient was treated with CNT0328 (CNT0328) SOLUTION (250 Mg) (View Cnt0328 (cnt0328) Solution Review and Cnt0328 (cnt0328) Solution Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), BUPRENORPHINE (BUPRENORPHINE) (View Buprenorphine (buprenorphine) Review and Buprenorphine (buprenorphine) Label ), PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ), AMOXICILLIN W/CLAVULANATE POTASSIUM (AMOXICILLIN, CLAVULANATE POTASSIU (View Amoxicillin W/clavulanate Potassium (amoxicillin, Clavulanate Potassiu Review and Amoxicillin W/clavulanate Potassium (amoxicillin, Clavulanate Potassiu Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

7012597-6 | Deep Vein Thrombosis, Headache, Localised Infection
Patient was taking Velcade (View Usage). After Velcade was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), headache (What is headache?), localised infection on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 161.8 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), pain (What is pain?) and. Velcade dosage: 1.0 Mg/m2, Unk. During the same period patient was treated with DOXIL (30 Mg/m2, Unk) (View Doxil Review and Doxil Label ), DEXAMETHASONE (20 Mg, Unk) (View Dexamethasone Review and Dexamethasone Label ), CYCLOPHOSPHAMIDE (750 Mg/m2, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), FRAGMIN (Unk) (View Fragmin Review and Fragmin Label ), OXYCODONE (Unk) (View Oxycodone Review and Oxycodone Label ), MIRALAX (Unk) (View Miralax Review and Miralax Label ), ZANTAC /00550802/ (150 Mg, Bid) (View Zantac /00550802/ Review and Zantac /00550802/ Label ), BACLOFEN (Unk) (View Baclofen Review and Baclofen Label ). Patient was hospitalized.

7010811-4 |
Adverse event was reported on Sep 21, 2010 by a Female patient taking Velcade (View Usage) (Dosage: 2.25 Mg, Cyclic) was diagnosed with mantle cell lymphoma and. Location: UNITED STATES , weighting 147.7 lb, . During the same period patient was treated with RITUXIMAB (649 Mg, Cyclic) (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (519 Mg, Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (2 Mg, Cyclic) (View Vincristine Review and Vincristine Label ), DOXORUBICIN HCL (86.5 Mg, Cyclic) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DEXAMETHASONE (40 Mg, Cyclic) (View Dexamethasone Review and Dexamethasone Label ), NEUPOGEN (300 Ug, Unk) (View Neupogen Review and Neupogen Label ). Patient was hospitalized.

7001603-0 |
on Sep 10, 2010 Male patient from UNITED STATES , 63 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). . Velcade dosage: 2.6 Mg, Cyclic. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), DECADRON (View Decadron Review and Decadron Label ), MORPHINE (View Morphine Review and Morphine Label ).

6992930-1 | Multiple Myeloma, Renal Failure
on Sep 10, 2010 Male patient from UNITED STATES , 60 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). After Velcade was administered, patient had the following side effects: multiple myeloma (What is multiple myeloma?), renal failure. Velcade dosage: 2.6 Mg, Cyclic. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), ELAVIL (View Elavil Review and Elavil Label ), LYRICA (View Lyrica Review and Lyrica Label ), TOPAMAX (View Topamax Review and Topamax Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), LASIX (View Lasix Review and Lasix Label ), POTASSIUM (View Potassium Review and Potassium Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ).

6992927-1 | Atrial Fibrillation, Cardiac Failure Congestive
Patient was taking Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure congestive on Sep 09, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 140.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Velcade dosage: 1.6 Mg/m2, Cyclic. During the same period patient was treated with THALIDOMIDE (100 Mg, Cyclic) (View Thalidomide Review and Thalidomide Label ), DEXAMETHASONE (20 Mg, Cyclic) (View Dexamethasone Review and Dexamethasone Label ), CARVEDILOL (12.5 Mg, Bid) (View Carvedilol Review and Carvedilol Label ), ALDACTONE (25 Mg, Bid) (View Aldactone Review and Aldactone Label ), ZOMETA (View Zometa Review and Zometa Label ), ELAVIL (Unk) (View Elavil Review and Elavil Label ), ZOFRAN (Unk) (View Zofran Review and Zofran Label ), LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ). Patient was hospitalized.

6992926-X | Constipation, Fall, Infusion Site Extravasation, Infusion Site Swelling
Adverse event was reported on Sep 09, 2010 by a Male patient taking Velcade (View Usage) (Dosage: 1.3 Mg/m2, Unk) was diagnosed with multiple myeloma (What is multiple myeloma?), hypertension and. Location: UNITED STATES , 76 years of age, Patient had the following side effects: constipation (What is constipation?), fall (What is fall?), infusion site extravasation, infusion site swelling. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.

6992618-7 | Cytomegalovirus Infection, Interstitial Lung Disease, Oedema Peripheral, Respiratory Failure
on Sep 08, 2010 Female patient from JAPAN , 75 years of age, weighting 70.55 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). After Velcade was administered, patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), interstitial lung disease, oedema peripheral, respiratory failure. Velcade dosage: 1 Mg/m2, Intravenous. During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), MAGLAX (MAGNESIUM OXIDE) (View Maglax (magnesium Oxide) Review and Maglax (magnesium Oxide) Label ), PANTOSIN (PANTETHINE) (View Pantosin (pantethine) Review and Pantosin (pantethine) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ALKERAN (View Alkeran Review and Alkeran Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6988290-2 | Colitis, Neutrophil Count Decreased, White Blood Cell Count Decreased
on Sep 08, 2010 Male patient from UNITED STATES , 65 years of age, weighting 274.3 lb, was treated with Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: colitis, neutrophil count decreased, white blood cell count decreased. Velcade dosage: 1.3 Mg/m2, Cyclic. During the same period patient was treated with FLAVOPIRIDOL (75 Mg/m2, Cyclic) (View Flavopiridol Review and Flavopiridol Label ). Patient was hospitalized.

6986931-7 |
Patient was taking Velcade (View Usage). on Sep 06, 2010 from BELGIUM Additional patient health information: Male patient , 65 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Velcade dosage: 1.0 Mg/m2, Unk.

6986124-3 | Anaemia, Atrial Fibrillation, Autonomic Neuropathy, Blood Creatinine Increased, Bronchitis Chronic, Decreased Appetite, Diarrhoea, Dyspnoea, Herpes Zoster
Adverse event was reported on Sep 02, 2010 by a Male patient taking Velcade (View Usage) (Dosage: 2.6 Mg, Subcutaneous) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UKRAINE , 61 years of age, weighting 187.2 lb, After Velcade was administered, patient had the following side effects: anaemia, atrial fibrillation (What is atrial fibrillation?), autonomic neuropathy, blood creatinine increased, bronchitis chronic, decreased appetite, diarrhoea, dyspnoea, herpes zoster. During the same period patient was treated with DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), BETAXOLOL (View Betaxolol Review and Betaxolol Label ), PAMIDRONIC ACID (PAMIDRONIC ACID) (View Pamidronic Acid (pamidronic Acid) Review and Pamidronic Acid (pamidronic Acid) Label ), LOPERAMIDE (LOPERAMIDE) (View Loperamide (loperamide) Review and Loperamide (loperamide) Label ). Patient was hospitalized.

6979467-0 | Cytomegalovirus Infection, Enterocolitis, Hyperamylasaemia, Pancreatitis Acute, Pneumonia Cytomegaloviral, Polyneuropathy, Thrombocytopenia, White Blood Cell Count Decreased
on Aug 30, 2010 Male patient from JAPAN , 58 years of age, weighting 163.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus infection (What is cytomegalovirus infection?), enterocolitis, hyperamylasaemia, pancreatitis acute, pneumonia cytomegaloviral, polyneuropathy, thrombocytopenia, white blood cell count decreased. Velcade dosage: 2.4 Mg, Cyclic, Intravenous. During the same period patient was treated with DEXAMETHASONE (20.00 Mg, Intravenous) (View Dexamethasone Review and Dexamethasone Label ), MUCOSTA (REBAMIPIDE) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ), LOXONIN (LOXOPROFEN SODIUM) (View Loxonin (loxoprofen Sodium) Review and Loxonin (loxoprofen Sodium) Label ), METHYCOBAL (MECOBALAMIN) (View Methycobal (mecobalamin) Review and Methycobal (mecobalamin) Label ), JUVELA (TOCOPHEROL) TABLET (View Juvela (tocopherol) Tablet Review and Juvela (tocopherol) Tablet Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), VALTREX (View Valtrex Review and Valtrex Label ), LAC B (LACTOBACILLUS BIFIDUS, LYOPHILIZED) (View Lac B (lactobacillus Bifidus, Lyophilized) Review and Lac B (lactobacillus Bifidus, Lyophilized) Label ). Patient was hospitalized and became disabled.

6978288-2 | Cardiomyopathy
on Sep 07, 2010 Female patient from AUSTRIA , weighting 110.2 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). Patient had the following side effects: cardiomyopathy (What is cardiomyopathy?). Velcade dosage: Unk. During the same period patient was treated with THALIDOMIDE (Unk) (View Thalidomide Review and Thalidomide Label ), DEXAMETHASONE (Unk) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6971831-9 | Asthenia, Decreased Appetite, Gait Disturbance, Malignant Neoplasm Progression, Multiple Myeloma, Weight Decreased
Patient was taking Velcade (View Usage). After Velcade was administered, patient had the following side effects: asthenia, decreased appetite, gait disturbance, malignant neoplasm progression, multiple myeloma (What is multiple myeloma?), weight decreased on Aug 27, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 54 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Velcade dosage: 1.7 Mg, Cyclic, Intravenous. During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), ERYTHROPOIETIN (ERYTHROPOIETIN) (View Erythropoietin (erythropoietin) Review and Erythropoietin (erythropoietin) Label ), MEGESTROL ACETATE (View Megestrol Acetate Review and Megestrol Acetate Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

6971553-4 | Dyspnoea, Hypoxia
Adverse event was reported on Aug 30, 2010 by a Male patient taking Velcade (View Usage) (Dosage: 1 Mg/m2, Cyclic) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , weighting 192.9 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, hypoxia. During the same period patient was treated with VORINOSTAT (300 Mg, Cyclic) (View Vorinostat Review and Vorinostat Label ). Patient was hospitalized.

6968901-8 | Angina Pectoris, Cardiac Failure Congestive, Cardiomegaly
on Aug 27, 2010 Female patient from UNITED STATES , 75 years of age, weighting 117.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). Patient had the following side effects: angina pectoris, cardiac failure congestive, cardiomegaly. Velcade dosage: 1.6 Mg/m2, Unk. During the same period patient was treated with DEXAMETHASONE (20 Mg, Unk) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6965592-7 | Muscular Weakness
on Aug 25, 2010 Female patient from UNITED STATES , weighting 135.0 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). After Velcade was administered, patient had the following side effects: muscular weakness. Velcade dosage: 2 Mg, 1/week.

6965575-7 | Chest Pain, Pancytopenia
Patient was taking Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), pancytopenia on Aug 24, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 197.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), pain (What is pain?) and. Velcade dosage: 2.5 Mg, 1/week. During the same period patient was treated with CALCIUM 600 + D (Unk) (View Calcium 600 + D Review and Calcium 600 + D Label ), OXYCODONE WITH APAP (Unk) (View Oxycodone With Apap Review and Oxycodone With Apap Label ), CYCLOBENZAPRINE HCL (10 Mg, Tid) (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), CLINDAMYCIN HYDROCHLORIDE (300 Mg, Tid) (View Clindamycin Hydrochloride Review and Clindamycin Hydrochloride Label ), PROPOXYPHENE NAPSYLATE W/PARACETAMOL (Unk) (View Propoxyphene Napsylate W/paracetamol Review and Propoxyphene Napsylate W/paracetamol Label ), FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ), ACYCLOVIR (200 Mg, Qd) (View Acyclovir Review and Acyclovir Label ), DEXAMETHASONE (40 Mg, Qd) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6965524-1 | Mucosal Inflammation, Pyrexia
Adverse event was reported on Sep 03, 2010 by a Male patient taking Velcade (View Usage) (Dosage: 1.30 Mg/m2, Unk) was diagnosed with b-cell lymphoma and. Location: UNITED STATES , 77 years of age, Patient had the following side effects: mucosal inflammation, pyrexia. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6960978-9 |
on Aug 23, 2010 Female patient from UNITED STATES , weighting 186.0 lb, was diagnosed with amyloidosis and was treated with Velcade (View Usage). . Velcade dosage: .

6960964-9 | Acidosis, Activated Partial Thromboplastin Time, Acute Respiratory Distress Syndrome, Alanine Aminotransferase, Alkalosis, Aspartate Aminotransferase, Blood Alkaline Phosphatase, Blood Bilirubin, Caecitis
on Aug 25, 2010 Male patient from UNITED STATES , 70 years of age, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, activated partial thromboplastin time, acute respiratory distress syndrome, alanine aminotransferase, alkalosis, aspartate aminotransferase, blood alkaline phosphatase, blood bilirubin, caecitis. Velcade dosage: 0.7 Mg/m2, Cyclic. During the same period patient was treated with ARA C (2000 Mg/m2, Cyclic) (View Ara-c Review and Ara-c Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ). Patient was hospitalized.

6960945-5 | Atrial Fibrillation
Patient was taking Velcade (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?) on Aug 24, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 205.0 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Velcade dosage: Unk. During the same period patient was treated with DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VORINOSTAT (Unk) (View Vorinostat Review and Vorinostat Label ). Patient was hospitalized.

6960316-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cardiac Valve Vegetation, Disease Progression, Fat Necrosis, Gastrointestinal Haemorrhage, Haemorrhagic Diathesis, Haemorrhagic Infarction, Haemosiderosis
Adverse event was reported on Aug 18, 2010 by a Male patient taking Velcade (View Usage) (Dosage: 2.00 Mg, Intravenous) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: JAPAN , 67 years of age, weighting 136.7 lb, After Velcade was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cardiac valve vegetation, disease progression, fat necrosis, gastrointestinal haemorrhage, haemorrhagic diathesis, haemorrhagic infarction, haemosiderosis. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), ORGARAN (View Orgaran Review and Orgaran Label ).

6955417-8 | Catheter Culture Positive, Deep Vein Thrombosis, Hypotension, Infection, Staphylococcus Test Positive, Supraventricular Tachycardia
on Aug 19, 2010 Female patient from UNITED STATES , weighting 131.0 lb, was diagnosed with amyloidosis, cough, nausea (What is nausea?), constipation (What is constipation?) and was treated with Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: catheter culture positive, deep vein thrombosis (What is deep vein thrombosis?), hypotension, infection (What is infection?), staphylococcus test positive, supraventricular tachycardia. Velcade dosage: 1.3 Mg/m2, Cyclic. During the same period patient was treated with MELPHALAN (50 Mg/m2, Cyclic) (View Melphalan Review and Melphalan Label ), DEXAMETHASONE (20 Mg, Cyclic) (View Dexamethasone Review and Dexamethasone Label ), BENZONATATE (100 Mg, Prn) (View Benzonatate Review and Benzonatate Label ), CODEINE SULFATE (15 Mg, Prn) (View Codeine Sulfate Review and Codeine Sulfate Label ), METOCLOPRAMIDE (10 Mg, Prn) (View Metoclopramide Review and Metoclopramide Label ), POLYETHYLENE GLYCOL (17 G, Prn) (View Polyethylene Glycol Review and Polyethylene Glycol Label ), COLACE (100 Mg, Tid) (View Colace Review and Colace Label ), SPIRONOLACTONE (25 Mg, Unk) (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6940139-X | Aplasia, Asthenia, Atrial Fibrillation, Confusional State, Cough, Cytolytic Hepatitis, Dyspnoea, Hyperglycaemia
on Aug 11, 2010 Male patient from FRANCE , 60 years of age, weighting 176.4 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). Patient had the following side effects: aplasia, asthenia, atrial fibrillation (What is atrial fibrillation?), confusional state, cough, cytolytic hepatitis, dyspnoea, hyperglycaemia. Velcade dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ERYTHROPOIETIN HUMAN (ERYTHROPOIETIN HUMAN) (View Erythropoietin Human (erythropoietin Human) Review and Erythropoietin Human (erythropoietin Human) Label ), MOEX (MOEXIPRIL) (View Moex (moexipril) Review and Moex (moexipril) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6939382-5 | Pneumonia Bacterial
Patient was taking Velcade (View Usage). After Velcade was administered, patient had the following side effects: pneumonia bacterial on Aug 18, 2010 from UNITED STATES Additional patient health information: Male patient , 77 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Velcade dosage: 2.5 Unk, Cyclic. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

6936937-9 | Disease Progression, Hepatic Function Abnormal, Herpes Zoster, Hypoaesthesia, Multiple Myeloma, Platelet Count Decreased, Urinary Tract Infection
Adverse event was reported on Aug 09, 2010 by a Male patient taking Velcade (View Usage) (Dosage: 1.5 Mg, Cyclic, Intravenous, 1.1 Cyclic, Intravenous) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: JAPAN , 65 years of age, weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: disease progression, hepatic function abnormal, herpes zoster, hypoaesthesia, multiple myeloma (What is multiple myeloma?), platelet count decreased, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with DEXAMETHASONE (20 Mg, Intravenous) (View Dexamethasone Review and Dexamethasone Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), COTRIM (View Cotrim Review and Cotrim Label ), CIPROXAN (CIPROFLOXACIN HYDROCHLORIDE) TABLET (View Ciproxan (ciprofloxacin Hydrochloride) Tablet Review and Ciproxan (ciprofloxacin Hydrochloride) Tablet Label ), BASEN (VOGLIBOSE) (View Basen (voglibose) Review and Basen (voglibose) Label ), AMARYL (View Amaryl Review and Amaryl Label ).

6936286-9 | Chalazion, Hordeolum, Periorbital Oedema
on Aug 13, 2010 Female patient from UNITED STATES , 64 years of age, weighting 119.0 lb, was treated with Velcade (View Usage). Patient had the following side effects: chalazion, hordeolum, periorbital oedema. Velcade dosage: .

6934063-6 | Acute Myeloid Leukaemia, Aspergillosis, Iiird Nerve Paralysis, Leukaemia Cutis
on Aug 12, 2010 Male patient from UNITED STATES , weighting 173.8 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). After Velcade was administered, patient had the following side effects: acute myeloid leukaemia, aspergillosis, iiird nerve paralysis, leukaemia cutis. Velcade dosage: Unk. During the same period patient was treated with MELPHALAN (Unk) (View Melphalan Review and Melphalan Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), ZOMETA (Unk) (View Zometa Review and Zometa Label ). Patient was hospitalized.

6934062-4 | Alanine Aminotransferase, Caecitis, Viral Infection
Patient was taking Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase, caecitis, viral infection (What is viral infection?) on Aug 12, 2010 from UNITED STATES Additional patient health information: Male patient , child 12 years of age, weighting 102.3 lb, was diagnosed with acute lymphocytic leukaemia and. Velcade dosage: 1.3 Mg/m2, Cyclic. During the same period patient was treated with METHOTREXATE (Unk Mg/m2, Cyclic) (View Methotrexate Review and Methotrexate Label ), ETOPOSIDE (100 Mg/m2, Cyclic) (View Etoposide Review and Etoposide Label ), CYCLOPHOSPHAMIDE (440 Mg/m2, Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6934060-0 | Dyspnoea
Adverse event was reported on Aug 17, 2010 by a Male patient taking Velcade (View Usage) (Dosage: 2 Mg, Cyclic) . Location: UNITED STATES , weighting 192.9 lb, Patient had the following side effects: dyspnoea. During the same period patient was treated with VORINOSTAT (300 Mg, Cyclic) (View Vorinostat Review and Vorinostat Label ). Patient was hospitalized.

6932870-7 | Cellulitis Orbital, Cerebral Infarction, Hypoxia, Influenza, Lung Consolidation, Lung Disorder, Mental Status Changes, Pyrexia, Renal Impairment
on Aug 11, 2010 Male patient from UNITED STATES , 69 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), influenza and was treated with Velcade (View Usage). After Velcade was administered, patient had the following side effects: cellulitis orbital, cerebral infarction, hypoxia, influenza, lung consolidation, lung disorder, mental status changes, pyrexia, renal impairment. Velcade dosage: . During the same period patient was treated with THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), OSELTAMIVIR (150 Mg, Bid) (View Oseltamivir Review and Oseltamivir Label ). Patient was hospitalized.

6931044-3 | Constipation, Fall, Infusion Site Extravasation, Infusion Site Swelling
on Aug 09, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), hypertension and was treated with Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), fall (What is fall?), infusion site extravasation, infusion site swelling. Velcade dosage: Unk. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.

6931043-1 | Deafness
Patient was taking Velcade (View Usage). Patient had the following side effects: deafness on Aug 09, 2010 from UNITED STATES Additional patient health information: Male patient , 76 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Velcade dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6931039-X |
Adverse event was reported on Aug 09, 2010 by a Male patient taking Velcade (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , weighting 128.3 lb, .

6931036-4 | Acute Leukaemia
on Aug 09, 2010 Male patient from UNITED STATES , weighting 160.0 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia. Velcade dosage: 2.3 Mg, Unk. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), DEXAMETHASONE (20 Mg, Unk) (View Dexamethasone Review and Dexamethasone Label ), ZOMETA (4 Mg, Unk) (View Zometa Review and Zometa Label ), GLIPIZIDE (2.5 Mg, Qd) (View Glipizide Review and Glipizide Label ). Patient was hospitalized.

6930138-6 | Aplasia, Atrial Fibrillation, Confusional State, Cytolytic Hepatitis, Hyperglycaemia, Leukopenia, Lung Infection
on Aug 04, 2010 Male patient from FRANCE , 60 years of age, weighting 176.4 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). Patient had the following side effects: aplasia, atrial fibrillation (What is atrial fibrillation?), confusional state, cytolytic hepatitis, hyperglycaemia, leukopenia, lung infection. Velcade dosage: . During the same period patient was treated with DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ERYTHROPOIETIN HUMAN (ERYTHROPOIETIN HUMAN) (View Erythropoietin Human (erythropoietin Human) Review and Erythropoietin Human (erythropoietin Human) Label ), MOEX (MOEXIPRIL) (View Moex (moexipril) Review and Moex (moexipril) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6930135-0 | Blood Amylase Increased, Constipation, Ileus, Neutrophil Count Decreased
Patient was taking Velcade (View Usage). After Velcade was administered, patient had the following side effects: blood amylase increased, constipation (What is constipation?), ileus, neutrophil count decreased on Aug 04, 2010 from JAPAN Additional patient health information: Female patient , 71 years of age, weighting 66.14 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), cancer pain and. Velcade dosage: 1.4 Mg, Intravenous. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (100 Mg, Oral) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), OXYCONTIN (10 Mg, Oral) (View Oxycontin Review and Oxycontin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), AMOBAN (ZOPICLONE) (View Amoban (zopiclone) Review and Amoban (zopiclone) Label ), NOVAMIN (PROCHLORPERAZINE) (View Novamin (prochlorperazine) Review and Novamin (prochlorperazine) Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

6926212-0 |
Adverse event was reported on Aug 06, 2010 by a Female patient taking Velcade (View Usage) (Dosage: 1.3 Mg/m2, Cyclic) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , weighting 128.0 lb, . During the same period patient was treated with DEXAMETHASONE (20 Mg, Cyclic) (View Dexamethasone Review and Dexamethasone Label ), THALIDOMIDE (100 Mg, Cyclic) (View Thalidomide Review and Thalidomide Label ).

6923992-5 | Pain, Pancytopenia
on Aug 05, 2010 Female patient from UNITED STATES , 55 years of age, weighting 197.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). Patient had the following side effects: pain (What is pain?), pancytopenia. Velcade dosage: 2.5 Mg, 1/week. Patient was hospitalized.

6923954-8 | West Nile Viral Infection
on Aug 05, 2010 Male patient from UNITED STATES , weighting 156.5 lb, was diagnosed with mantle cell lymphoma and was treated with Velcade (View Usage). After Velcade was administered, patient had the following side effects: west nile viral infection. Velcade dosage: 1.3 Mg/m2, Cyclic. During the same period patient was treated with CYCLOPHOSPHAMIDE (600 Mg, Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ), DEXAMETHASONE (40 Mg, Cyclic) (View Dexamethasone Review and Dexamethasone Label ), RITUXIMAB (375 Mg/m2, Cyclic) (View Rituximab Review and Rituximab Label ), ACYCLOVIR (400 Mg, Bid) (View Acyclovir Review and Acyclovir Label ), LEVOTHYROXINE (125 Mg, Qd) (View Levothyroxine Review and Levothyroxine Label ), LORAZEPAM (1 Mg, Prn) (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6919818-6 | Atrial Fibrillation, Confusional State, Renal Failure, Skin Exfoliation
Patient was taking Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), confusional state, renal failure, skin exfoliation on Aug 02, 2010 from UNITED STATES Additional patient health information: Male patient , 79 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Velcade dosage: 2.5 Mg, 1/week. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (Unk) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ), REVLIMID (Unk) (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6918054-7 | Chest Pain, Dyspnoea, Hypotension, Pneumonia, Pyrexia
Adverse event was reported on Jul 31, 2010 by a Male patient taking Velcade (View Usage) (Dosage: 1.3 Mg/m2, Cyclic) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , weighting 196.2 lb, Patient had the following side effects: chest pain (What is chest pain?), dyspnoea, hypotension, pneumonia (What is pneumonia?), pyrexia. During the same period patient was treated with DEXAMETHASONE (20 Mg, Cyclic) (View Dexamethasone Review and Dexamethasone Label ), LENALIDOMIDE (25 Mg, Cyclic) (View Lenalidomide Review and Lenalidomide Label ), ASPIRIN (325 Mg, Qd) (View Aspirin Review and Aspirin Label ), AMPICILLIN SODIUM (View Ampicillin Sodium Review and Ampicillin Sodium Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ), FLAGYL (View Flagyl Review and Flagyl Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), MAXIPIME (View Maxipime Review and Maxipime Label ). Patient was hospitalized.

6917499-9 | Blood Lactate Dehydrogenase Increased, Chest Pain, Chills, Dyspnoea, Pyrexia
on Jul 30, 2010 Female patient from NETHERLANDS , 69 years of age, weighting 213.8 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). After Velcade was administered, patient had the following side effects: blood lactate dehydrogenase increased, chest pain (What is chest pain?), chills, dyspnoea, pyrexia. Velcade dosage: 2.75 Mg, Intravenous, 2 Mg, Intravenous. During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

6917497-5 | Malignant Neoplasm Progression, Multiple Myeloma, Varicella
on Jul 28, 2010 Female patient from JAPAN , 60 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Velcade (View Usage). Patient experienced the following unwanted or unexpected effects: malignant neoplasm progression, multiple myeloma (What is multiple myeloma?), varicella. Velcade dosage: 2 Mg, Intravenous. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MUCOSTA (REBAMIPIDE) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ).

6911764-7 | Uraemic Neuropathy, Urinary Tract Infection
Patient was taking Velcade (View Usage). Patient had the following side effects: uraemic neuropathy, urinary tract infection (What is urinary tract infection?) on Jul 29, 2010 from UNITED STATES Additional patient health information: Female patient , 43 years of age, . Velcade dosage: 1.3 Mg/m2, Cyclic. Patient was hospitalized.